allogeneic hematopoietic cell
A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation *
... To cite this article: Eline M.P. Cremers, Theo de Witte, Liesbeth de Wreede, Diderik-Jan Eikema, Linda Koster, Anja van Biezen, Jürgen Finke, Gerard Socié, Dietrich Beelen, Johan Maertens, Arnon Nagler, Guido Kobbe, ...
13
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning
... after allogeneic hematopoietic cell transplantation (HCT) has remained unclear thus ...given allogeneic hemato- poietic stem cells after either nonmyeloablative (n ¼ 176) or high-dose (n ¼ ...
5
Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning
... by allogeneic hematopoietic cell transplantation (HCT) has been recognized as an effective therapy for a number of hematologic malignancies with tumor cells resistant to conventional doses of ...
26
Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
... after allogeneic hematopoietic cell transplantation (HCT) with nonmyeloablative condition- ...after allogeneic HCT with nonmyeloablative ...
7
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
... Introduction Allogeneic hematopoietic cell transplantation (allo- HCT) is commonly offered to patients with acute mye- loid leukemia (AML) as a curative treatment ...
12
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
... USA Allogeneic hematopoietic cell transplantation (HCT) following nonmyeloablative conditioning has been extensively evaluated in patients with hematologic malignancies who are ineligible for ...
11
Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age
... T-cell receptor beta chain (TCRB) CDR3 spectratyping analyses were performed between two and nine (median three) years after HCT in 21 patients. RNA was extracted from 10¥10 6 cells by Tripure (Roche) according to ...
9
Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age.
... HLA-mismatched related or unrelated donors. PBSC were unmanipulated in 56 patients, CD8-depleted in 19 others, and CD34-selected in the remaining 5 patients. GVHD prophylaxis consisted of mycophenolate mofetil and ...
2
ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.
... For the purpose of this analysis, eligible patients were adults over the age of 18 with AML who were transplanted from an HLA mis- matched donor at one or two loci (8/10; 9/10) (-A, -B, -C, DRB1, -DQB1). Patients who had ...
8
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
... RHuEPO therapy The first 14 NMHCT recipients did not receive rHuEPO (control group) and were previously reported [33] . For the prospective phase II trial, we decided to start rHuEPO on day 30 (EPO group 1, n 5 27), ...
10
Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC
... helpful for decision-making in terms of transplant, they overlook key transplant-related variables [ 6 , 7 ]. The main body of literature investigating prognostic factors assessed after hematopoietic cell ...
8
Current roles for allogeneic hematopoietic cell transplantation following nonmyeloablative or reduced-intensity conditioning.
... Since allogeneic HCT has been the only curative treatment for MDS, 37 it is not surprising that several reports address the effi cacy of nonablative HCT for ...
15
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)
... editor. Hematopoietic Stem Cell ...given allogeneic hematopoietic cell transplanta- tion after nonmyeloablative ...to Allogeneic Stem Cell Transplantation (allo-SCT) From ...
7
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)
... al. Allogeneic hematopoietic cell transplant for prolymphocytic ...stem cell transplantation in T-prolymphocytic leuke- mia: a retrospective study from the European Group for Blood and Marrow ...
5
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin.
... Inclusion/exclusion criteria and study endpoints Inclusion criteria included adult patients, de novo or secondary AML, myeloablative conditioning, MSD or 10/10 HLA-matched unrelated donors (MUD), first or second CR, ...
9
Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells
... DiscUssiOn Allogeneic NK cells have been shown to be effective in the treat- ment of poor prognosis acute myeloid and lymphoid leukemia (AML and ALL) ( 34 , 37 – 42 ...that allogeneic activated NK cells ...
12
Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the plasma cell disorders subcommittee of the european group for blood and marrow transplant chronic malignancies working party
... for allogeneic HSCT in MM, which is the salvage allo-HSCT after one or two auto-HSCTs using ...and allogeneic stem cell trans- plantation suggests a selection of high-risk patients in the presented ...
4
The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study
... final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA). Bone Marrow Transplant. 2012; 47:684–693. 37. Majhail NS, ...
30
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
... tumor cell population and/or playing a critical role for neoplastic cell ...squamous cell carcinoma of the head and neck [2, ...Fc-antibody-dependent cell-mediated cytotoxicity ...B- ...
29
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
... dence of cGvHD, similar OS, and better patient-reported outcomes at 5 years after transplantation than those ran- domized to the PBSC arm. 4,5 This might suggest that, at least in the MUD setting, BM may be preferred ...
10